Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis.

Choi WM, Kim HH, Kim MH, Cinar R, Yi HS, Eun HS, Kim SH, Choi YJ, Lee YS, Kim SY, Seo W, Lee JH, Shim YR, Kim YE, Yang K, Ryu T, Hwang JH, Lee CH, Choi HS, Gao B, Kim W, Kim SK, Kunos G, Jeong WI.

Cell Metab. 2019 Aug 20. pii: S1550-4131(19)30430-9. doi: 10.1016/j.cmet.2019.08.001. [Epub ahead of print]

PMID:
31474565
2.

Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer.

Kang YE, Kim JT, Lim MA, Oh C, Liu L, Jung SN, Won HR, Lee K, Chang JW, Yi HS, Kim HJ, Ku BJ, Shong M, Koo BS.

Cancers (Basel). 2019 Aug 12;11(8). pii: E1154. doi: 10.3390/cancers11081154.

3.

Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases.

Yi HS.

Endocrinol Metab (Seoul). 2019 Mar;34(1):39-46. doi: 10.3803/EnM.2019.34.1.39. Review.

4.

T-cell senescence contributes to abnormal glucose homeostasis in humans and mice.

Yi HS, Kim SY, Kim JT, Lee YS, Moon JS, Kim M, Kang YE, Joung KH, Lee JH, Kim HJ, Chun K, Shong M, Ku BJ.

Cell Death Dis. 2019 Mar 13;10(3):249. doi: 10.1038/s41419-019-1494-4.

5.

Overcoming osteoporosis and beyond: Locomotive syndrome or dysmobility syndrome.

Yi HS, Lee S.

Osteoporos Sarcopenia. 2018 Sep;4(3):77-78. doi: 10.1016/j.afos.2018.09.001. Epub 2018 Sep 18. No abstract available.

6.

Experimental Applications of in situ Liver Perfusion Machinery for the Study of Liver Disease.

Choi WM, Eun HS, Lee YS, Kim SJ, Kim MH, Lee JH, Shim YR, Kim HH, Kim YE, Yi HS, Jeong WI.

Mol Cells. 2019 Jan 31;42(1):45-55. doi: 10.14348/molcells.2018.0330. Epub 2018 Dec 12.

7.

Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.

Kim M, Kim HI, Jeon MJ, Kim HK, Kim EH, Yi HS, Kim ES, Kim H, Kim BH, Kim TY, Kim SW, Kang HC, Kim WB, Chung JH, Shong YK, Kim TH, Kim WG.

Oral Oncol. 2018 Dec;87:97-103. doi: 10.1016/j.oraloncology.2018.10.029. Epub 2018 Oct 26.

PMID:
30527251
8.

Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.

Kim M, Kim HK, Kim HI, Kim EH, Jeon MJ, Yi HS, Kim ES, Kim H, Kim TH, Kim BH, Kim TY, Kang HC, Kim WB, Chung JH, Shong YK, Kim SW, Kim WG.

Oral Oncol. 2018 Nov;86:48-52. doi: 10.1016/j.oraloncology.2018.09.008. Epub 2018 Sep 13.

PMID:
30409319
9.

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance.

Kang YE, Kim JM, Yi HS, Joung KH, Lee JH, Kim HJ, Ku BJ.

Diabetes Metab J. 2019 Jun;43(3):368-376. doi: 10.4093/dmj.2018.0066. Epub 2018 Oct 23.

10.

The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases

Yi HS, Chang JY, Shong M.

J Mol Endocrinol. 2018 Oct 1;61(3):R91-R105. doi: 10.1530/JME-18-0005.

11.

CX3CR1 differentiates F4/80low monocytes into pro-inflammatory F4/80high macrophages in the liver.

Lee YS, Kim MH, Yi HS, Kim SY, Kim HH, Kim JH, Yeon JE, Byun KS, Byun JS, Jeong WI.

Sci Rep. 2018 Oct 10;8(1):15076. doi: 10.1038/s41598-018-33440-9.

12.

Genetic Analysis of CLCN7 in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.

Kim SY, Lee Y, Kang YE, Kim JM, Joung KH, Lee JH, Kim KS, Kim HJ, Ku BJ, Shong M, Yi HS.

Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.

13.

Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study.

Jeon MJ, Kim HK, Kim EH, Kim ES, Yi HS, Kim TY, Kang HC, Shong YK, Kim WB, Kim BH, Kim WG.

Thyroid. 2018 Sep;28(9):1121-1127. doi: 10.1089/thy.2018.0159. Epub 2018 Jul 23.

PMID:
29897005
14.

The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases.

Yi HS, Chang JY, Shong M.

J Mol Endocrinol. 2018 May 30. pii: JME-18-0005. doi: 10.1530/JME-18-0005. [Epub ahead of print]

PMID:
29848625
15.

Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer.

Lee J, Yi S, Won M, Song YS, Yi HS, Park YJ, Park KC, Kim JT, Chang JY, Lee MJ, Sul HJ, Choi JE, Kim KS, Kero J, Kim J, Shong M.

Oncogene. 2018 Aug;37(32):4455-4474. doi: 10.1038/s41388-018-0211-6. Epub 2018 May 10.

PMID:
29743590
16.

Clinical Implications of UCP1 mRNA Expression in Human Cervical Adipose Tissue Under Physiological Conditions.

Lee JH, Kim JM, Choi MJ, Kang YE, Joung KH, Yi HS, Kim KS, Ku BJ, Koo BS, Shong M, Kim HJ.

Obesity (Silver Spring). 2018 Jun;26(6):1008-1016. doi: 10.1002/oby.22188. Epub 2018 Apr 26.

17.

Reduced oxidative capacity in macrophages results in systemic insulin resistance.

Jung SB, Choi MJ, Ryu D, Yi HS, Lee SE, Chang JY, Chung HK, Kim YK, Kang SG, Lee JH, Kim KS, Kim HJ, Kim CS, Lee CH, Williams RW, Kim H, Lee HK, Auwerx J, Shong M.

Nat Commun. 2018 Apr 19;9(1):1551. doi: 10.1038/s41467-018-03998-z.

18.

Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice.

Lee YS, Kim DY, Kim TJ, Kim SY, Jeong JM, Jeong WI, Jung JK, Choi JK, Yi HS, Byun JS.

Biochem Biophys Res Commun. 2018 Mar 18;497(4):957-962. doi: 10.1016/j.bbrc.2018.01.191. Epub 2018 Feb 2.

PMID:
29410095
19.

Upregulation of RSPO2-GPR48/LGR4 signaling in papillary thyroid carcinoma contributes to tumor progression.

Kang YE, Kim JM, Kim KS, Chang JY, Jung M, Lee J, Yi S, Kim HW, Kim JT, Lee K, Choi MJ, Kang SK, Lee SE, Yi HS, Koo BS, Shong M.

Oncotarget. 2017 Nov 25;8(70):114980-114994. doi: 10.18632/oncotarget.22692. eCollection 2017 Dec 29.

20.

Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex.

Kim SY, Jeong JM, Kim SJ, Seo W, Kim MH, Choi WM, Yoo W, Lee JH, Shim YR, Yi HS, Lee YS, Eun HS, Lee BS, Chun K, Kang SJ, Kim SC, Gao B, Kunos G, Kim HM, Jeong WI.

Nat Commun. 2017 Dec 21;8(1):2247. doi: 10.1038/s41467-017-02325-2.

Supplemental Content

Loading ...
Support Center